Chibroxin(Chibroxine 0.3%), 3 mg/ml, eye drops, solution
Norfloxacinum
Chibroxin and Chibroxine 0.3% are different trade names for the same medicine.
Chibroxin is a broad-spectrum antibacterial medicine in the form of eye drops.
It is indicated for the treatment of eye infections (of the eyes) caused by certain types of bacteria.
Chibroxin is indicated for the local treatment of eye infections.
Before starting to use Chibroxin, discuss it with your doctor or pharmacist.
Tell your doctor about any previous illnesses and current complaints, as well as any drug allergies.
If you experience eye irritation or new symptoms, such as eye redness or eyelid swelling, see your doctor immediately.
If you suspect that an allergic reaction (hypersensitivity) has occurred after using Chibroxin (e.g., rash, redness, and itching of the eyes), stop using the medicine and see your doctor immediately.
Tell your doctor if you experience worsening of the infection, eye injury, or have undergone eye surgery, as well as if you experience new symptoms or worsening of existing ones.
Do not wear contact lenses while using Chibroxin:
Tell your doctor about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
If you are using different types of eye drops, wait at least 15 minutes between administering different medicines. Eye ointments should always be applied last.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor or pharmacist before using this medicine.
Using the medicine during pregnancy and breastfeeding is not recommended.
Some side effects reported after using Chibroxin may affect your ability to drive or use machines (see section 4. Possible side effects).
If such effects occur, do not drive or use machines during this period.
Chibroxin contains benzalkonium chlorideas a preservative.
The medicine contains 0.025 ml of benzalkonium chloride per 1 ml of solution.
Benzalkonium chloride may be absorbed by soft contact lenses and change their color. If you wear contact lenses, tell your doctor before starting to use Chibroxin.
Do not wear contact lenses during treatment.
If you do wear them, remove the contact lenses before administering the eye drops and wait at least 15 minutes before putting them back on.
Benzalkonium chloride may cause punctate keratitis and (or) toxic ulcerative keratitis.
Benzalkonium chloride may also cause eye irritation, especially in people with dry eye syndrome or corneal disorders (the transparent layer on the front of the eye). If you experience abnormal sensations in the eye, stinging, or eye pain after using the medicine, contact your doctor.
Always use this medicine exactly as your doctor or pharmacist has told you.
If you are unsure, ask your doctor or pharmacist.
Your doctor will decide the dose and duration of treatment.
Usually, one or two drops of Chibroxin are instilled into the affected eye (eyes) four times a day.
Depending on the severity of the infection, on the first day of treatment, one or two drops of the medicine can be instilled every two hours, during waking hours, during the day. During the visit, the doctor should check the effectiveness of the antibacterial action of the medicine.
Do not change the dose without consulting your doctor. If you need to stop using the medicine, see your doctor immediately.
Before using Chibroxin, remove your contact lenses.
Use Chibroxin as directed by your doctor.
If you miss a dose, use it as soon as you remember. However, if it is almost time for your next dose, do not use the missed dose, but return to your original dosing schedule.
Do not use a double dose to make up for a missed dose.
If you accidentally instill too much medicine or swallow the contents of the bottle, contact your doctor immediately.
If you have any further questions about using this medicine, ask your doctor or pharmacist.
Like all medicines, Chibroxin can cause side effects, although not everybody gets them.
If you experience symptoms of hypersensitivity to Chibroxin or other severe side effects, do not instill the next dose. Contact your doctor or the Emergency Department of your nearest hospital immediately.
If you suspect that an allergic reaction (hypersensitivity) has occurred after using Chibroxin (e.g., rash, redness, and itching of the eyes) or a severe side effect, stop using the medicine and contact your doctor or the Emergency Department of your nearest hospital immediately.
While using Chibroxin, you may experience:
Eye disorders
Very common (affecting more than 1 in 10 people): local burning or stinging sensation.
Uncommon (affecting 1 in 100 to 1 in 1000 people): eye redness (hyperemia of the conjunctiva), swelling of the conjunctiva, bitter taste in the mouth after instillation of the medicine.
Rare (affecting less than 1 in 10000 people): deposits (white spots) in the cornea, i.e., the transparent membrane covering the front of the eye.
Frequency not known (cannot be estimated from available data): photophobia (sensitivity to light).
Other side effects occur less frequently, but some of them may be severe.
Due to the presence of benzalkonium chloride, there is a risk of contact dermatitis and irritation.
If you experience any side effects, including any not listed in this leaflet, tell your doctor.
If you experience any side effects, including any not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department for Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181 C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children.
Do not store above 25°C. Keep the bottle in the outer packaging.
Do not use this medicine after the expiry date stated on the packaging.
Shelf life after first opening the bottle: 15 days.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Chibroxin is an eye drop solution in a bottle with a dropper, protective ring, and cap, in a cardboard box.
A polyethylene bottle with a dropper in a cardboard box containing 5 ml of 0.3% solution.
For more detailed information, contact the marketing authorization holder or parallel importer.
Laboratoires Thea
12 Rue Louis Bleriot
63017 Clermont-Ferrand Cedex 2
France
Excelvision
Rue de la Lombardière
07100 Annonay
France
Laboratoires Thea
12, rue Louis Blériot
63017 Clermont-Ferrand Cedex 2
France
InPharm Sp. z o.o.
ul. Strumykowa 28/11
03-138 Warsaw
InPharm Sp. z o.o. Services sp. k.
ul. Chełmżyńska 249
04-458 Warsaw
Marketing authorization number in France, the country of export:3400933132255
Parallel import authorization number:409/24
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.